Drammen sykehus
15
5
6
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
20.0%
3 terminated/withdrawn out of 15 trials
66.7%
-19.8% vs industry average
33%
5 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)
Role: collaborator
Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer
Role: collaborator
A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease
Role: collaborator
Skin-to-skin After Delivery in Preterm Infants Born at 28-32 Weeks of Gestation
Role: collaborator
Exercise Training Study of Patients With Claudicatio Intermittens
Role: collaborator
Personalized Training for People With Rare Neuromuscular Disorders
Role: collaborator
The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation
Role: collaborator
Management of Patients with Heart Failure At Home After Hospital Discharge
Role: collaborator
The Norwegian Cerebral Venous Thrombosis Study
Role: collaborator
Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
Role: collaborator
Norwegian Capture the Fracture Initiative
Role: collaborator
Atrial Fibrillation in Cryptogenic Stroke and TIA
Role: collaborator
Antibiotics In Modic Changes
Role: collaborator
Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection
Role: collaborator
Prediction and Secondary Prevention of Fractures
Role: collaborator
All 15 trials loaded